Clinical Advances in Nasopharyngeal Carcinoma : Episode 6
Opinion
Video
Tailoring NPC Treatment: Patient Populations, EBV Titer Monitoring, and Key External Factors
Author(s):
Experts on nasopharyngeal carcinoma outline the role of immunotherapy and discuss external factors that inform treatment decisions.
EP: 1.Differentiating Nasopharyngeal Carcinoma from Other Head & Neck Cancers: The Value of a Multidisciplinary Approach
EP: 2.Current Guidelines for Managing Nasopharyngeal Carcinoma
EP: 3.Overview of the JUPITER and POLARIS-2 Trials
EP: 4.Value of PD-L1 Biomarker in NPC
EP: 5.Phase 3 DIPPER Trial: Adjuvant PD-1 Blockade with Camrelizumab
Now Viewing
EP: 6.Tailoring NPC Treatment: Patient Populations, EBV Titer Monitoring, and Key External Factors
EP: 7.Strategies to Mitigate Adverse Events in Nasopharyngeal Carcinoma Treatment
EP: 8.Future Research Needs for Neoadjuvant/Adjuvant PD-1 Blockade in Nasopharyngeal Carcinoma
Video content above is prompted by the following:
- Is there a specific patient population that might benefit from this treatment?
- Are there any external factors that may impact your treatment selection? Are you monitoring your patients for EBV titer?
Related Videos
Related Content
